Termination, Settlement Agreement and Mutual Release
Contract Categories:
Business Operations
- Termination Agreements
EX-10.66 3 ex1066settlementagreementa.htm SETTLEMENT AGREEMENT Ex 10.66 SETTLEMENTAGREEMENTANDMUTUALRELEASE
The Spectranetics Corporation
9965 Federal Drive
Exhibit 10.66
Termination, Settlement Agreement and Mutual Release
This Termination, Settlement Agreement and Mutual Release ("Agreement") is made and entered into this March 14, 2012 (the “Effective Date”) by and between The Spectranetics Corporation (“Spectranetics”) and Kensey Nash Corporation (“KNC”).
1. Definitions. Upper case terms used in this Agreement without definition will have the meaning given that term in the Asset Purchase Agreement (defined below). Spectranetics and KNC specifically acknowledge that the phrase “improvements or other deliverables developed under the Services Agreement” as that phrase is used in the definition of “Acquired Technology” in the Asset Purchase Agreement includes the ThromCat, ThromCat XT 7F and ThromCat XT 6F.
“APA Documents” means the: Asset Purchase Agreement; Development and Regulatory Services Agreement; License Agreement; Manufacturing and License Agreement; and Non-Competition Agreement.
“Asset Purchase Agreement” is the Asset Purchase Agreement between Spectranetics and KNC dated May 12, 2008, together with all of its schedules and exhibits.
“Development and Regulatory Services Agreement” is the Development and Regulatory Services Agreement dated May 30, 2008 between Spectranetics and KNC as amended by an Amendment dated June 22, 2009.
“Equipment” means items of equipment listed on Exhibit A.
“Inventory” means raw materials, work in progress, and finished goods relating to the Acquired Technology that is in KNC’s possession as of the Effective Date as listed on Exhibit B.
“KNC Parties” means KNC and all present and past employees, servants, agents, representatives, officers, directors, successors, predecessors and affiliates of KNC.
“License Agreement” is the License Agreement between Spectranetics and KNC and executed and delivered as part of the closing of the transactions in the Asset Purchase Agreement.
“Manufacturing and Licensing Agreement” is the Manufacturing and Licensing Agreement dated May 30, 2008 between Spectranetics and KNC.
“Non-Competition Agreement” is the Non-Competition Agreement dated May 30, 2008 among Spectranetics, KNC, and ILT Acquisition Sub, Inc.
“Records” means (i) “Manufacturing Records” (manufacturing build records, device master records in the form and version as of the Effective Date, device history records and lot history records), and (ii) “Development Records” (design history files) of the Acquired Technology.
“Spectranetics Parties” means Spectranetics and all present and past employees, servants, agents, representatives, officers, directors, successors, predecessors and affiliates of Spectranetics.
2. Termination of Existing Agreements.
1
a. Spectranetics and KNC are parties to the APA Documents. Spectranetics and KNC have a variety of disagreements relating to performance and payments under the various APA Documents, about which they have been having discussions and meetings.
b. Except as specifically provided in subsection (c) below, Spectranetics and KNC agree that each of APA Documents is terminated as of the Effective Date by the mutual agreement of Spectranetics and KNC and that all future rights and obligations of the Spectranetics Parties and KNC Parties pursuant to the APA Documents are no longer required or expected.
c. The only terms of the Spectranetics Parties and KNC Parties remaining under the APA Documents will be as follows (collectively, the “Ongoing Terms”). Any provisions in the APA Documents calling for survival of terms after a termination is deemed void.
Agreement | Section | Relating to |
Asset Purchase Agreement | Section 6.1 | Confidentiality |
Article X | Miscellaneous | |
Manufacturing and License Agreement | Section 10 without the introductory phrase in Section 10.1 “Except as specifically set forth herein”. | Intellectual Property Rights |
Section 11 | Confidential Information | |
Section 12, but solely to the extent of activities of Spectranetics and KNC prior to the Effective Date. | Warranties and Representations | |
Section 16; and sections of the Manufacturing and License Agreement containing representations, warranties and covenants that trigger the indemnification provided in Section 16, but solely for the purpose of the obligations in Section 16. | Indemnification | |
Section 17 | Miscellaneous Provisions | |
Non-Competition Agreement | Amended, as set forth at Exhibit C. | |
License Agreement | In its entirety. | Orthopedic uses. |
Development and Regulatory Services Agreement | Section 7.2 | Inventions |
The first sentence of Section 7.3 | Patent Prosecution and Maintenance | |
Section 7.5 | Other Rights | |
Section 8 | Confidential Information | |
Section 12; and sections of the Development and Regulatory Services Agreement containing representations, warranties and covenants that trigger the indemnification obligations provided in Section 12, but solely for the purpose of the obligations in Section 12. | Indemnification |
2
Section 13 | Miscellaneous Provisions | |
APA Documents | Defined terms contained in sections not listed above that are required in order to understand the listed section. |
3. Settlement Payments and Deliveries.
a. Cash Payment. Within ten business days from Effective Date, Spectranetics will deliver to KNC the sum of $1.7 million in cash, by wire transfer of immediately available funds to one or more accounts designated in writing by KNC. KNC and Spectranetics will treat this payment as a payment under the Development and Regulatory Services Agreement.
b. Records. Within 60 days from the Effective Date, KNC will deliver to Spectranetics all of the Records, which have not been previously delivered, in electronic format that is readable and usable by software and equipment common to medical device businesses in the ordinary course of business. In the event that KNC or Spectranetics discovers some of the Records were not delivered, KNC will diligently cooperate with Spectranetics to assure that any missing Records are delivered promptly.
c. Inventory. Within 10 business days of the Effective Date, Spectranetics will send KNC written notice indicating whether it will require KNC to: (i) destroy or dispose of the Inventory or (ii) pack and ship the Inventory to Spectranetics at KNC’s cost. In either event KNC will fulfill the chosen option not later than 60 days from the Effective Date.
d. Equipment.
i. Except for the items specifically listed on Exhibit A – List #2, which are hereby transferred to KNC, free and clear of all liens and encumbrances, all items purchased by Spectranetics pursuant to the Asset Purchase Agreement will remain the property of Spectranetics. In particular, and without limiting the generality of the foregoing, Spectranetics and KNC specifically acknowledge that the items on Exhibit A – List #1 are owned by Spectranetics even though the items are in the possession of third parties.
ii. Effective as of the Effective Date, Spectranetics sells, assigns, transfers, conveys and delivers to KNC, and KNC does purchase and accept from Spectranetics, all right, title and interest in, to and under the Equipment listed on Exhibit A-List #2, free and clear of all liens, mortgages, charges, security interests, pledges or other encumbrances or adverse claims or interests of any nature.
e. THE PARTIES HERETO ACKNOWLEDGE THAT, EXCEPT AS OTHERWISE EXPRESSLY INDICATED IN THIS AGREEMENT, THERE ARE NO WARRANTIES WHATSOEVER WITH RESPECT TO THE INVENTORY OR EQUIPMENT, INCLUDING WITHOUT LIMITATION IMPLIED WARRANTIES OF FITNESS FOR ANY PARTICULAR USE, AND ALL WARRANTIES OTHER THAN THOSE EXPRESSLY SET FORTH IN THIS AGREEMENT ARE HEREBY DISCLAIMED.
4. Reasonable Cooperation. Spectranetics and KNC will each provide the other with: (i) reasonable cooperation after the Effective Date in order to allow each of them to comply with applicable law or regulation; and (ii) up to 40 hours of additional time in order to support Spectranetics’ use of the Acquired Technology, Equipment on List #1, and Records in the ordinary course of business, no later than December 31, 2013. KNC will maintain Records in accordance with its internal policies for the maintenance thereof.
3
5. Mutual Release.
a. KNC for the KNC Parties releases, acquits and forever discharges the Spectranetics Parties from any and all actions, causes of action, suits, claims, demands, rights, controversies, debts, agreements, damages, costs, expenses, liabilities and compensation whatsoever (collectively, “Claims”) which any of the KNC Parties now have or may hereafter have against any of the Spectranetics Parties on account of or arising out of any matter, thing, or event which has happened, developed or occurred, whether known or unknown, at any time prior to the Effective Date, specifically including, but not limited to, any and all claims of any kind stemming from, arising out of, or in any way related to any of the obligations and payments under the APA Documents.
b. Spectranetics for the Spectranetics Parties releases, acquits and forever discharges the KNC Parties from any and all Claims which any of the Spectranetics Parties now have or may hereafter have against any of the KNC Parties on account of or arising out of any matter, thing, or event which has happened, developed or occurred, whether known or unknown, at any time prior to the Effective Date, specifically including, but not limited to, any and all claims of any kind stemming from, arising out of, or in any way related to any of the obligations and payments under the APA Documents.
c. The KNC Parties and Spectranetics Parties do not release each other from any Claims arising out of the breach or alleged breach of this Agreement or the Ongoing Terms.
6. Unknown Facts. KNC for the KNC Parties and Spectranetics for the Spectranetics Parties acknowledge that they are aware that they or their attorneys may later discover facts different from or in addition to the facts which they now know or believe to be true with respect to the subject matter of this Agreement, but that it is their intention to, and they do, fully, finally, absolutely, and forever settle any and all claims, disputes and differences which do now exist, may exist, or may have existed between them, and that in furtherance of such intention, the mutual general release given above shall be, and remain, in effect as a full and complete mutual general release, notwithstanding any mistake of fact or the discovery of any different or additional facts.
7. Compromise. This Agreement is entered into solely for purposes of compromise, and each of the KNC Parties and Spectranetics Parties expressly acknowledges and agrees that the other parties have not admitted, and by the execution and performance of this Agreement do not admit, and in fact, expressly deny, any liability or obligation to the other parties.
8. Representations and Warranties. KNC represents and warrants for each of the KNC Parties and Spectranetics represents and warrants for each of the Spectranetics Parties that:
a. This Agreement has been duly approved by its governing body, which governing body has authorized the undersigned officer to sign on behalf of that entity.
b. It has been represented by and advised by independent counsel of its own choice throughout all negotiations which preceded the execution of this Agreement, and in connection with its execution of this Agreement.
4
c. It has not assigned, transferred, or liened, or purported to assign, transfer, or lien, voluntarily or involuntarily, to any person or entity, any Claim or any part or portion thereof, which is released by this Agreement.
9. Miscellaneous.
a. Successors and Assigns. The provisions of this Agreement will be deemed to bind, obligate and extend to, and inure to the benefit of each of the KNC Parties and Spectranetics Parties and their successors and assigns, including those who may assume any or all of the above-described capacities subsequent to the Effective Date.
b. Entire Agreement and Amendment. This Agreement contains the entire agreement and understanding between the Spectranetics Parties and the KNC Parties relating to its subject matter and supersedes and replaces all prior negotiations or proposed agreements, written or oral. None of the Spectranetics Parties or KNC Parties has entered into this Agreement in reliance upon any promise, representation or warranty not contained in this Agreement. Each party has fully and carefully read the foregoing Agreement, knows and understands its contents, and signs it freely. This Agreement may be amended only by a writing signed by both Spectranetics and KNC.
c. Method of Signing. This Agreement may be executed electronically and in two or more counterparts, each of which will be deemed an original and all together will constitute one and the same instrument.
d. Public Disclosure. Neither Spectranetics nor KNC will make any disclosure (whether or not in response to an inquiry) of the subject matter of this Agreement unless previously approved in writing by the other party or as required by law. Each party agrees not to unreasonably withhold or delay approval.
e. Governing Law and Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware without regard to any applicable conflicts of law rules or principles. Each party hereto hereby submits to the exclusive jurisdiction of the United States District Court for the District of Delaware and of any Delaware state court sitting in the County of New Castle, State of Delaware for purposes of all legal proceedings arising out of or relating to this Agreement or the transactions contemplated hereby.
IN WITNESS WHEREOF, each of the undersigned has signed this Termination, Settlement Agreement and Mutual Release.
The Spectranetics Corporation By: /s/ Wade Bowe | Kensey Nash Corporation By: /s/ Joseph Kaufmann |
Wade Bowe, Vice President | Joseph Kaufmann, CEO |
5
Exhibit A
List #1 | |||
KNC Asset Number | SPNC Asset Number | Description | Tool # |
9324 | 0 | Tooling for Extraction Catheter D | 0 |
N/A | Drive Assy. Pressure Tester | T5460-A | |
N/A | Harness Test Fixture | T3969-A | |
8620 | Mold for Part #4311-01 (Strain Relief TCat, Precision Polymer Product Inc.) | N/A | |
10240 | Mods to Distal Tip Mold FA#9817 (Distal Tip, Mikrotech LLC.) | 0 | |
3064 | 0 | Mold for Part# 4009 (Motor Shaft Gear, K2 Plastics) | N/A |
8703 | REVISE MOLD FOR 4137 (Top Enclosure TCat, AIM Plastics) | N/A | |
8714 | TFX Production Tray Tooling | 0 | |
9200 | Injection Mold for Part 4125 (Strain Relief, Precision Polymer Product Inc.) | 0 | |
9201 | INJECTION MOLDS for 4112-01 (Diaphragm, Precision Polymer Product Inc.) | 0 | |
10220 | Multi Cavity TFX Distal Tip Mold (Distal Tip, Mikrotech LLC.) | T-4675-A | |
CIP | 4293 | Mod. to Mold for P/N 4104-01 | N/A |
CIP | 4294 | Next Generation "Multi-Cavity" Distal Tip Mold | |
8748 | SINGLE CAVITY LIM TOOL | 0 | |
9816 | MODS TO IMPRESSION ASSEMBLY, TFX | T-4122-A | |
9817 | MODS TO MOLD BASE, TFX DISTAL TIP (Mikrotech LLC.) | T-4123-A | |
10368 | 0 | New Label Stock Die for QuickCat | N/A |
couldn't tag | Germany Assets | N/A | |
9569 | Second Vendor Catheter Tooling | N/A | |
10522 | 0 | 2nd QC Vendor | N/A |
9756 | Thromcat Cutting Die Revision 425 (Label Stock, CCL Label) | 0 |
Exhibit A continues on next page.
6
Exhibit A, continued
Exhibit A - List #2 | |||
KNC Asset Number | SPNC Asset Number | Description | Tool # |
CIP | 4272 | Resistance Test Station | T5521-A |
10313 | Caltex Video Microscope | T5455-A | |
1853 | 0 | Balance | 1657-L |
2272 | Guidewire Swagging Block for Fenn | 0 | |
3469 | 0 | Balance Portable 4100G 120V | T3478-A |
3512 | Programmable Convection Oven | T3448-A | |
8567 | ESD Test Simulator | 0 | |
8744 | Bollard Grips | 0 | |
9104 | Balloon Development Station | T3039-C | |
9444 | PN 4278-NTC Swiss Lathe Tooling ( | N/A | |
9540 | Ball Valve Mainfold | 0 | |
9897 | Micrometer | 0 | |
9899 | Laptop - production | 0 | |
9908 | Power Source - Monitors | 0 | |
9911 | Function Generator | 0 | |
10039 | Fluke Digital Multimeter | T-5189A | |
10044 | Safety Analyzer | T-5074-A | |
10495 | 0 | Arterial Demo Models for Sales | N/A |
10496 | 0 | Arterial Demo Models for Sales | N/A |
10497 | 0 | Arterial Demo Models for Sales | N/A |
10498 | 0 | Arterial Demo Models for Sales | N/A |
9541 | 3866 | CATHETER STANDS | T2648 A-E |
9312 | 3980 | Sprint Tester | T4019-D |
9313 | 3981 | Sprint Tester | T4019 D |
9501 | 3964 | INLINE FEEDER | T4587-A |
9864 | 3985 | Additions to Inline Feeder | T-4587-B |
2884 | 4804 | Flush Cath Holding Stand | 0 |
8561 | Ross High Shear Mixer/Disperser/Emulsifier | T-4072-A | |
1216 | 3918 | Clamp for Camera | T1993-A |
1795 | 3919 | IMAGE PRO PLUS SOFTWARE W/ CAMERA | 0 |
2650 | 3913 | Leiss Axiovert 25 CA Microscope | 0 |
4318 | 4x5 Fully Automatic Camera for Sc | 0 | |
8399 | NEED NUMBER | Bench Oven | T3455-B |
7
Exhibit A, continued
8630 | 4251 | Metering Pump | 0 |
8833 | 3915 | Vertex 230 Measuring Center | T3052B |
9754 | 3910 | Dynamic Proximal Torque Sensor fo | 0 |
9755 | 4041 | Non-Contact Distal Torque Sensor | 0 |
9880 | 3917 | 2 Kg submersible AUX load cell, f | 0 |
9881 | 3916 | Top-Freezer Refrigerator | 0 |
9905 | 3873 | RAM Microscope System | T-4614-A |
9925 | 3867 | Torchbox | T-4615-C |
9926 | 3855 | Oscilloscope | T-5188-A |
9580 | 3938 | Stainless Steel Table | N/A |
9581 | 3900 | Stainless Steel Table | N/A |
9627 | 4250 | Sony Technolook Video Microscope | T4505-B |
2652 | 3914 | Buehler Metaserv 2000 Grinder Pol | T2962-A |
3334 | 3942 | Haake Immersion Circulator | T2807-D |
3529 | 3894 | Talboys Stirrer | T3389-A |
3534 | 3892 | Humidity Chamber | T3514-A |
3554 | 3893 | Chart Recorder for Convection Ove | T3485-A |
4391 | 4038 | Load Cell for MTS Tensile Tester | T3199-A |
8407 | 3890 | Environmental Chamber | T2668-C |
8408 | 3891 | Environmental Chamber | T2668-D |
8651 | 0 | Brookfield Viscometer | T4129-A |
9761 | 4039 | MTS Pneumatic Grips | T-4635-A |
9959 | 3897 | 1000 N Load Cell for MTS System | T-3197-B |
3871 | NRE Cost for process development-Catheter Coating | N/A | |
838 | 3881 | Xenon Light Source | 0 |
1088 | 3927 | Trinocular Microscope | T1993A |
3057 | 3885 | EKG Machine | 0 |
3563 | 3934 | Pressure Senor 0 to 30 PSI | T3560-A |
3564 | 3933 | Pressure Senor 150 PSI | T3561-A |
3726 | 3884 | Patient Simulator and Accessories | T3663-A |
3840 | 3937/3936 | Mechanical Testing Grip (Self Tig | T3901A |
3885 | 3959 | Metricath System | 0 |
8566 | 3928 | Beta Laser Mike BALLOON MEASURING | T4114-A |
8692 | 3925 | Airflow Systems High Efficient In | T-4131-A |
708 | 4042 | ZSB ZOOM STEREO MICROSCOPE | T1316-J |
8792 | Oscilloscope | T4337-A | |
9487 | 4260 | Canon Power Shot Digital Camera | 0 |
8
Exhibit A, continued
9620 | 0 | Video Camera | 0 |
1325 | Underside Lighting for Lab Benche | 0 | |
9752 | 3856 | HIPOT Tester for ILT | T4724-B |
9803 | 3820 | Standard Hot Air Station | T-4941-A |
9907 | 3858 | Leakage Tester | T-4724-A |
9919 | 4019 | Torch Box | T-4615-A |
3509 | 4253 | Ultrasonic Cleaner | T1946A |
3775 | Stiffness Tester | T-3804-A | |
8504 | Sprint LC Tester | T4019-B | |
8949 | 4255 | Sony DCR-HC42 MiniDV Digital Hand | 0 |
9747 | 3879 | Unitron ZSB Stereo Microscope | T-1316 CY |
10011 | 3922 | ZSB Stero Microscope | T-1316-DB |
3333 | 3956 | Haake Immersion Circulator | T2807-C |
3622 | 3954 | Harland Friction Test System | T3625-A |
8472 | 0 | Haake Immersion Circulator | T-2807-H |
599 | 4254 | NECROPSY TABLE | 0 |
2473 | 3923 | Stereo Microscope Maier Wild M3Z | T-2861-A |
3248 | 3909 | Refrigerated Incubator | T3358-A |
3822 | 3943 | Haake Immersion Circulator | T2807D |
3924 | 4036 | SFA Anatomical Leg Model | T-3879-A |
8473 | 3941 | Haake Immersion Circulator | T2807-G |
8596 | 3880 | ZSB Stereo Microscope | T1316-BZ |
8880 | 3946 | EFD Ultra Adhesive Dispenser | 0 |
9621 | 4037 | Arterial Model | N/A |
9949 | 3905 | Pulsatile Blood Pump | T-3830-E |
10012 | 3940 | ZSB Stero Microscope | T-1316-DC |
10214 | 3908 | Tenney Classic Environmental Test | T-5513-A |
3519 | 3974 | Large Animal Harvard Pump | T3830-D |
9340 | couldn't tag | Portable Heart Models for Demos for sales | N/A |
9341 | couldn't tag | Portable Heart Models for Demos for sales | N/A |
9584 | couldn't tag | Portable Demo Models | N/A |
N/A | Balance, Analytical, 120 g Max | T1657-R | |
N/A | Corning stirrer plate | T4577-A & B | |
N/A | Hot Air Torch Boc | T4615-C | |
N/A | Programmable AC Power Source | T5185-A | |
N/A | ILT Solder Fixture | T4611-C,D |
9
Exhibit A, continued
N/A | Torquer Clip Assembly Tool | T5494-A,B | |
N/A | Rotating Soldering Fixture | T5268-A,B | |
N/A | Safe-Cross .014 Inch Straight Manual Polisher | T5498-A,B | |
N/A | Safe-Cross .035 Inch Angled Manual Polisher | T5499-A,B | |
N/A | Digital Hot Air Pen | T4689-C | |
N/A | Hypo-tube Inspection System | T5063-A | |
N/A | Automatic Polishing Tool | T4969-A | |
N/A | Gauge Pin, .0350 | T4904-A,B,C | |
CIP | 4291 | Hypotube Measurement Device (from ILT) | N/A |
CIP | Never Completed | Hypotube Handling Fixture | T4467-A |
720 | 3883 | INTERSPEC APOGEE ULTRASOUND SYSTEM | 0 |
8381 | 3924 | RF Welder | T4007-A |
3135 | 3929 | Laser Welding System | T3240-A |
9913 | 3886 | Laser Welder w/ video system | T-4628-A |
CIP | 4289 | Thromcat FULL Braided Jacket/Catheter | |
CIP | CMI Phase II | N/A | |
9898 | 3902 | Safe-Cross System Item# 60087 | 0 |
9814 | 3901 | Haake DC10 Circulator & Water Bat | T-2807-I |
994 | 3957 | Pulsatile Blood Pump | T3830-A |
1740 | 4040 | Large Animal Harvard Pump | T3830-B |
2683 | 3906 | DC10 Immersion Circulator | T2708-A |
3332 | 3907 | Haake Immersion Circulator | T2807-B |
3819 | 3958 | Pulsatile Blood Pump | T3830-C |
8486 | 3944 | Haake Immersion Circulator | T2807-F |
9815 | 3903 | Haake DC10 Circulator & Water Bat | T-2807-J |
8631 | 3869 | IDTE 2000 Catheter Testing Equipm | T4108-A |
3025 | 3931 | MTS Tensile Tester | T3199-A |
10
Exhibit B
[List out Inventory. See Definition.]
11
Exhibit B
Item | Description | UOM | Subinventory | |||||||||||||
Quantity | Value | |||||||||||||||
ENDO.FG | ||||||||||||||||
63000-02 | THROMCAT KIT, EU | EA | 2 | 1,659.7 | ||||||||||||
Category Total: | 1,659.7 | |||||||||||||||
ENDO.RAW MATL | ||||||||||||||||
002862-01 | FLUX, LIQUID | EA | 4 | 19.28 | ||||||||||||
003088-02 | SILICONE FLUID, MED 420 | EA | 1.6 | 95.39 | ||||||||||||
003126-02 | SCREW, SOC-HD CAP, #2-56 X 1/4, ST STL | EA | 600 | 20.34 | ||||||||||||
003391-01 | O-RING, AS-568-010 70BNB | EA | 408 | 69.36 | ||||||||||||
003391-02 | O-RING, AS-568-008 70BNB | EA | 118 | 27.14 | ||||||||||||
003391-03 | O-RING, AS-568-011 70BNB | EA | 347 | 22.9 | ||||||||||||
003391-04 | O-RING, AS-568-.083 x .035 70BNB | EA | 370 | 88.8 | ||||||||||||
003451-02 | 1 1/2 x 10 TUBING SET BAND | EA | 8,760 | 41.7 | ||||||||||||
003451-03 | 3/4 X 2 CATHETER BAND, SLANTED EDGES | EA | 10,443 | 109.65 | ||||||||||||
003657-07 | RADIOPAQUE BAND, .0605 OD | EA | 2,953 | 3,779.84 | ||||||||||||
003657-16 | RADIOPAQUE BAND, .0636 OD | EA | 505 | 1,474.6 | ||||||||||||
003838-01 | SPRING, LEE CI-010D-02-S | EA | 728 | 333.42 | ||||||||||||
003838-04 | SPRING, LEE LC-029E-14-S | EA | 206 | 156.97 | ||||||||||||
003838-08 | SPRING, LEE LC-022C-00 S | EA | 997 | 311.06 | ||||||||||||
003857-05 | IN-PROCESS PROTECTOR | EA | 1,000 | 779 | ||||||||||||
003909-01 | HOSE GROMMET,.25 ID | EA | 203 | 9.11 | ||||||||||||
003956-02 | #2-28X3/8,TX PLUS PH PLAS | EA | 300 | 27 | ||||||||||||
003957-01 | #4-20 X 3/4 TX PLUS PH PLAS | EA | 816 | 38.35 | ||||||||||||
003993-01 | PROCEDURE KIT SHIPPER | EA | 313 | 397.51 | ||||||||||||
004009-01 | ASM, MOTOR SHAFT GEAR | EA | 166 | 929.6 | ||||||||||||
004083-01 | HELIX, ROUND-WIRE | EA | 60 | 139.8 | ||||||||||||
004083-02 | HELIX, ROUND-WIRE, LONG | EA | 1,032 | 3,023.76 | ||||||||||||
004085-01 | MOTOR SUPPORT | EA | 299 | 304.98 | ||||||||||||
004094-01 | DRIVE HOUSING, TFX DEVICE | EA | 152 | 270.41 | ||||||||||||
004096-01 | FACE SEAL | EA | 87 | 516.78 | ||||||||||||
004097-01 | CTRL KNOB HEX | EA | 163 | 347.19 | ||||||||||||
004098-01 | EXTRACTION HAT | EA | 762 | 449.58 | ||||||||||||
004101-01 | INFUSATE CORE, BAG-SIDE | EA | 627 | 551.76 | ||||||||||||
004104-01 | CTRL KNOB CLAMP | EA | 150 | 268.5 | ||||||||||||
004105-01 | INFUSATE CATH. JACKET | EA | 7,663 | 6,743.44 | ||||||||||||
004106-01 | INFUSATE CLAMP | EA | 1,592 | 939.28 | ||||||||||||
004107-01 | WIRING HARNESS, BLACK ROCKER SWITCH | EA | 16 | 248.32 | ||||||||||||
004107-03 | WIRING HARNESS, TERMINATED | EA | 176 | 3,016.64 | ||||||||||||
004108-01 | FLARE NUT | EA | 150 | 191.7 |
1
004112-01 | DIAPHRAGM, EXTRACTION, THROMCAT XT | EA | 291 | 2,211.6 | ||||||||||||
004118-01 | POWER SUPPLY, THROMCAT DEVICE | EA | 131 | 3,836.99 | ||||||||||||
004120-01 | BEARING, ID .125 X OD .313 | EA | 458 | 819.82 | ||||||||||||
004120-02 | BEARING, ID .125 X OD .375 | EA | 450 | 805.5 | ||||||||||||
004120-04 | BEARING, ID .0937 X OD .1875 | EA | 318 | 693.24 | ||||||||||||
004120-05 | BEARING, ID .125 X OD .313, EXTENDED INNER RACE | EA | 418 | 961.4 | ||||||||||||
004122-01 | SPIKE, INFUSATE BAG | EA | 648 | 83.59 | ||||||||||||
004124-01 | INFUSATE SLEEVE, BAG SIDE | EA | 2,326 | 1,925.93 | ||||||||||||
004125-01 | STRAIN RELIEF, JACKET | EA | 188 | 197.4 | ||||||||||||
004127-01 | SEGMENTED LUMEN | EA | 206 | 18,319.58 | ||||||||||||
004136-01 | BOTTOM ENCLOSURE, TFX | EA | 53 | 127.2 | ||||||||||||
004137-01 | TOP ENCLOSURE, TFX | EA | 58 | 292.9 | ||||||||||||
004137-02 | TOP ENCLOSURE, AS MOLDED, TFX | EA | 262 | 1,467.2 | ||||||||||||
004148-01 | EXTRACTION TUBING SET, THROMCAT XT | EA | 2,754 | 12,227.76 | ||||||||||||
004174-01 | TUBE CLAMP, .250 X .040 | EA | 189 | 23.68 | ||||||||||||
004175-01 | ASM, DRIVE SHAFT GEAR | EA | 24 | 118.8 | ||||||||||||
004205-01 | VENTED CAP FOR SPIKE | EA | 437 | 16.61 | ||||||||||||
004236-01 | THROMCAT TRAY | EA | 273 | 1,037.4 | ||||||||||||
004237-01 | THROMCAT TRAY INSERT | EA | 154 | 585.2 | ||||||||||||
004238-01 | RUBBER, FOAM | EA | 676 | 162.24 | ||||||||||||
004243-01 | M3 X 8MM SOCKET HEAD | EA | 160 | 17.22 | ||||||||||||
004250-01 | SPRING EYELET, .183 O.D. X .344 L | EA | 1,098 | 50.51 | ||||||||||||
004251-01 | THROMCAT SHELF BOX | EA | 47 | 93.06 | ||||||||||||
004251-02 | PRINTED THROMCAT SHELFBOX | EA | 1,188 | 3,942.97 | ||||||||||||
004259-01 | BEARING SLEEVE, FRONT | EA | 546 | 2,293.2 | ||||||||||||
004281-01 | AC POWER CORD, THROMCAT DEVICE | EA | 59 | 177 | ||||||||||||
004304-02 | TYVEK LID, OVERSIZED | EA | 554 | 306.2 | ||||||||||||
004310-01 | MECHANICAL THROMBECTOMY DEVICE IFU | EA | 23 | 11.62 | ||||||||||||
004311-01 | STRAIN RELIEF, SPIKE, 3" | EA | 2,297 | 2,411.85 | ||||||||||||
004330-02 | SHIPPER FOAM CORNER, 11.06" X 6.00" X 1.13" | EA | 324 | 346.68 | ||||||||||||
004338-01 | OVERLAY, SWITCH, RUN/OFF | EA | 847 | 433.66 | ||||||||||||
004380-01 | SANOPRENE, BLUE | GM | 101,052.64 | 2,439.41 | ||||||||||||
004397-01 | TUBE, SILICONE | EA | 12,978 | 2,011.59 | ||||||||||||
004412-01 | LABEL STOCK, THERMAL TRANSFER DIE CUT, 6.5IN X 8.00IN | EA | 6,977 | 316.97 | ||||||||||||
004412-02 | LABEL STOCK, THERMAL TRANSFER DIE CUT, 6.5IN X 8.00IN, WHITE | EA | 3,405 | 0 | ||||||||||||
004412-03 | LABEL STOCK, THERMAL TRANSFER SIDE DIE CUT, 6.5IN X 8.00IN | EA | 1,839 | 116.81 | ||||||||||||
004414-01 | THROMCAT INSTRUCTIONS FOR USE, EU | EA | 168 | 1,442.28 | ||||||||||||
004426-01 | GROUNDED POWER CORD, US | EA | 1,932 | 3,323.04 | ||||||||||||
004449-01 | BEARING SLEEVE, REAR | EA | 151 | 314.08 | ||||||||||||
004465-03 | 440C, ROD, .1875 O.D. | EA | 18 | 256.5 | ||||||||||||
004484-01 | TECOTHANE, COMPOUNDED | GM | 41,938.62 | 1,610.44 | ||||||||||||
004485-01 | TECOFLEX EG-100A | GM | 21,599 | 829.4 |
2
004497-03 | 416H, ROD, .1875 OD | EA | 3 | 29.69 | ||||||||||||
004502-01 | CORE SLEEVE, DISTAL | EA | 304 | 1,030.56 | ||||||||||||
004503-01 | INFUSATE LUMEN ASM CATHETER END | EA | 83 | 2,649.36 | ||||||||||||
004507-01 | HELIX, VARIABLE PITCH, 72.00 | EA | 416 | 4,721.6 | ||||||||||||
004515-01 | PTFE ROD, 25% CARBON FILLED. .25 DIA | EA | 107 | 545.7 | ||||||||||||
004520-01 | HELIX, 45 PITCH | EA | 1 | 9.5 | ||||||||||||
004524-01 | TOP ENCLOSURE, THROMCAT XT | EA | 262 | 1,362.4 | ||||||||||||
004531-01 | SHAFT SEAL, THROMCAT XT | EA | 168 | 613.2 | ||||||||||||
004542-01 | JACKET, FULL-BRAIDED, 7F | EA | 132 | 16,104 | ||||||||||||
004543-02 | SWITCH, ROCKER, GRAY | EA | 238 | 731.61 | ||||||||||||
004544-01 | FASTON, FLAG .250 X .032, 22-18 AWG | EA | 2,996 | 139.91 | ||||||||||||
004544-02 | FASTON, FLAG .250 X .032, 16-14 AWG | EA | 996 | 56.47 | ||||||||||||
004551-01 | THROMCAT XT INSTRUCTIONS FOR USE, OUS | EA | 105 | 948.89 | ||||||||||||
004558-01 | SPECTRANETICS LABEL STOCK, 6.50" X 5.75" | EA | 6,100 | 366 | ||||||||||||
004558-02 | SPECTRANETICS LABEL STOCK, 6.50" X 6.75" | EA | 4,420 | 364.65 | ||||||||||||
004584-01 | CONNECTOR PIN, FEMALE | EA | 600 | 16.2 | ||||||||||||
004587-01 | ROD, ALLOY 360 BRASS, .3750 O.D. | EA | 1 | 23.5 | ||||||||||||
004588-01 | ROD, AISI 12L14 LEAD STEEL, .1875 O.D. | EA | 5 | 33.05 | ||||||||||||
004589-01 | RUBBER EDGE TRIM | IN | 550 | 735.63 | ||||||||||||
005753-01 | 19 X 24 TYVEK/NYLN POUCH | EA | 43 | 123.32 | ||||||||||||
Category Total: | $ | 125,006.93 | ||||||||||||||
ENDO.SUBASSY | ||||||||||||||||
004100-01 | EXTRACTION CORE CLAMP, TFX DEVICE | EA | 324 | 8,522.8 | ||||||||||||
004119-01 | TFX DEVICE | EA | 52 | 40,205.26 | ||||||||||||
004121-01 | EXTRACTION CATHETER ASM, TFX | EA | 1 | 200.11 | ||||||||||||
004126-01 | DRIVE SHAFT, TFX DEVICE | EA | 200 | 6,468.54 | ||||||||||||
004146-01 | INFUSATE CATHETER ASM | EA | 48 | 1,476.81 | ||||||||||||
004272-01 | DRIVE SHAFT, 1-PC, THROMCAT XT | EA | 24 | 338.1 | ||||||||||||
004277-01 | TIP, DISTAL ASM | EA | 260 | 19,028.83 | ||||||||||||
004517-01 | DRIVE SHAFT ASSEMBLY | EA | 29 | 1,224.82 | ||||||||||||
004521-01 | EXTRACTION CATHETER ASM, XT | EA | 1 | 238.72 | ||||||||||||
004526-01 | THROMCAT XT DEVICE | EA | 38 | 27,408.31 | ||||||||||||
004532-01 | SPACER, SHAFT SEAL, THROMCAT XT | EA | 57 | 585.97 | ||||||||||||
Category Total: | $ | 105,698.27 | ||||||||||||||
Report Total: | $ | 232,364.9 |
3
Exhibit C
NON-COMPETITION AGREEMENT
This Non-Competition Agreement (the “Agreement”) is made and entered into as of March 14, 2012 (the “Effective Date”), by and among The Spectranetics Corporation, a Delaware corporation (the “Purchaser”), on the one hand, and Kensey Nash Corporation, a Delaware corporation (the “Company”), and ILT Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ILT” and, together with the Company, the “Seller Parties”), on the other hand.
W I T N E S S E T H
WHEREAS, pursuant to an Asset Purchase Agreement, dated as of May 12, 2008 (the “Asset Purchase Agreement”) by and among the Purchaser and the Seller Parties, the Purchaser has acquired from the Seller Parties, by purchase, the Acquired Assets; and
WHEREAS, as the Purchaser and the Seller Parties have agreed to terminate the relationship created pursuant to the Asset Purchase Agreement, and the related Transaction Documents, as set forth in the Termination, Settlement Agreement and Mutual Release, dated on even date herewith.
NOW, THEREFORE, the parties hereto, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, do hereby agree as follows:
1.Definitions. Capitalized terms used herein have the respective meanings as defined in the Asset Purchase Agreement; provided, however that for purposes of this Agreement only, the following definitions will apply:
“Business” shall mean the business of marketing or selling the Acquired Technology in the fields of chronic total occlusions and thrombus management.
“Change of Control Transaction” shall mean the acquisition of greater than fifty percent (50%) of the Seller’s outstanding voting shares of stock, or other transaction effecting a change of control from the current board of directors of the Seller, by or to, as appropriate, a party who would otherwise be a third party to this Agreement.
2.Covenant Not to Compete. For a period commencing on the Effective Date and ending on the earlier of September 30, 2017, a Change of Control Transaction or the expiration date of the last to expire of the Patent Rights:
(a)Competition. Each of the Seller Parties and their Affiliates will not, knowingly, directly or indirectly, whether as a consultant, independent contractor or advisor, or in any other capacity whatsoever (i) enter into or engage in any business or other enterprise that competes with the Business, or (ii) render, offer or attempt to render or solicit the rendition of services that competes with the Business to, any business, individual or other enterprise (or a portion, division or business line
1
of a business, individual or other enterprise) that is in competition with the Business; provided, however, that the provisions of this Paragraph 2(a) shall not be deemed to prohibit either Seller Party’s ownership of not more than five percent (5%) of the total shares of all classes of stock outstanding of any publicly held company. For purposes of clarity under this Agreement, and not by way of limitation, a business, individual or enterprise will be deemed to be “in competition” or “competes” with the Business if the activities of such business, individual or enterprise involve the, distribution, marketing, or sale of products that compete with the Acquired Technology in the fields of chronic total occlusions or thrombus management.
(b)Non-Interference. The Seller Parties and their Affiliates will not directly solicit or knowingly induce or attempt to induce any provider, payor, customer, supplier, distributor, licensor, licensee, consultant, agent or other business relation of the Purchaser, whether existing or prospective at such time (each, a “Business Relation”), to cease doing business related to the Business or alter its business relationship as it relates to the Business with the Purchaser or in any way knowingly interfere with the existing or prospective business relationship between any such Business Relation and the Purchaser as it relates to the Business.
(c)Purchaser Name and Logo. The Seller Parties and their Affiliates will not use, cause to be used or induce the use of, the Purchased Names or any derivation thereof in connection with any business or other enterprise or any other name or mark (including any logo) that has such a near resemblance thereto as may be likely to cause confusion or mistake to the public, or to otherwise deceive the public.
(d)Injunctive Relief. Each of the Seller Parties acknowledges that monetary damages may not be sufficient to compensate the Purchaser for any economic loss that may be incurred by reason of breach of the foregoing restrictive covenants. Accordingly, in the event of any such breach, the Purchaser shall, in addition to any remedies available to the Purchaser at law, be entitled to seek equitable relief in the form of an injunction enjoining any of the Seller Parties from continuing to engage in such breach. Each of the Seller Parties agrees that no bond or other indemnity shall be required to be posted by the Purchaser in connection with the granting of any request for a preliminary or permanent injunction.
(e)Non-Disparagement. The Seller Parties and their Affiliates agree that the Seller Parties will not disparage the Business, the Purchaser or its Affiliates, or any past, current or future stockholder, director, officer, employee, consultant, agent or independent contractor of the Purchaser or its Affiliates in any communication with any third party; provided, however, that the foregoing will not preclude any of the Seller Parties from bringing such actions in law or in equity as are appropriate to protect its or their interests. Similarly, the Purchaser agrees that the Purchaser will not disparage the Seller Parties or their Affiliates, or any past, current or future stockholder, director, officer, employee, consultant, agent or independent contractor of any Seller Party or its Affiliates in any communication with any third party; provided, however, that the foregoing will not preclude the Purchaser from bringing such actions in law or in equity as are appropriate to protect its interests.
(f)Limitation on Restrictions. If any restriction set forth in this Paragraph 2 is held to be unenforceable, then the Seller Parties and the Purchaser agree, and hereby submit, to the reduction and limitation of such prohibition to such area or period as shall be deemed enforceable by
2
any court of competent jurisdiction.
3.Certain Representations of the Seller Parties. Each of the Seller Parties represents that the limitations set forth in Paragraph 2 (including without limitation, time and territorial limitations) are reasonable and properly required for the adequate protection of the Business being acquired by the Purchaser for the consideration set forth in the Asset Purchase Agreement. It is understood that the covenants made by each of the Seller Parties in Paragraphs 2(d) through 2(f) shall survive the expiration or termination of this Agreement.
4.Assignment. The Seller Parties shall not assign or delegate any of its or their rights or obligations under this Agreement without the prior written consent of the Purchaser. The Purchaser may assign its rights or obligations to any of its Affiliates so long as it controls any such Affiliate.
5.Entire Agreement. This Agreement contains the entire agreement between the parties with respect to the subject matter hereof.
6.Waivers and Amendments. This Agreement may be amended, superseded, canceled, renewed or extended, and the terms may be waived, only by a written instrument signed by each of the parties hereto. No delay on the part of any party in exercising any right, power or privilege under this Agreement shall operate as a waiver, nor will any waiver on the part of either party of any such right, power or privilege, preclude any further exercise thereof or exercise or any other such right, power or privilege.
7.Successors and Assigns. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the Purchaser and its successors and permitted assigns and the Seller Parties and each of the Seller Parties’ legal representatives, heirs, legatees, distributes and transferees by operation of law, whether or not any such person shall have become a party to this Agreement and have agreed in writing to join and be bound by the terms and conditions hereof. Any assignor shall not be relieved from any obligations or liabilities under this Agreement.
8.Governing Law. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware without regard to any applicable conflicts of law rules or principles.
9.Consent to Jurisdiction; Venue; Waiver of Certain Damages and Jury Trial.
(a)Except where it is pursuant to the terms of this Agreement entitled to injunctive relief, prior to commencing any litigation in connection with this Agreement or the other Transaction Documents, each party hereto shall use commercially reasonable efforts to cause its chief executive officer to confer with the chief executive officers of the other parties hereto for a period of at least 30 days, and each party hereto shall use its commercially reasonable efforts to resolve such dispute. Only after compliance with the provisions of this Paragraph 9(a) may a party hereto commence an action in connection with this Agreement or the other Transaction Documents.
3
(b)Each party hereto hereby submits to the exclusive jurisdiction of the United States District Court for the District of Delaware and of any Delaware state court sitting in the County of New Castle, State of Delaware for purposes of all legal proceedings arising out of or relating to this Agreement or the transactions contemplated hereby. Each party hereto irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of the venue of any such proceeding brought in such a court and any claim that any such proceeding brought in such a court has been brought in an inconvenient forum, and the parties hereto irrevocably agree that all such proceedings shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Paragraph 11 or in such other manner as may be permitted by law shall be valid and sufficient service thereof.
(c)Each party hereto waives any claim to punitive, exemplary or multiplied damages from the other; provided, however, that this waiver shall not be deemed to prevent any Purchaser Indemnified Party or Seller Indemnified Party from recovering Losses incurred by such Purchaser Indemnified Party or Seller Indemnified Party, as the case may be, as a result of any claim (i) from any third party for any such punitive, exemplary or multiplied damages imposed upon such Purchaser Indemnified Party or Seller Indemnified Party and as to which claim such Purchaser Indemnified Party or Seller Indemnified Party, as the case may be, is otherwise entitled to indemnification under Section 9.2 of the Asset Purchase Agreement in the case of Purchaser Indemnified Parties or Section 9.3 of the Asset Purchase Agreement in the case of Seller Indemnified Parties or (ii) for fraud.
(d)Waiver of Jury Trial EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS OR EVENTS CONTEMPLATED HEREBY OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY HERETO. THE PARTIES HERETO EACH AGREE THAT ANY AND ALL SUCH CLAIMS AND CAUSES OF ACTION SHALL BE TRIED BY THE COURT WITHOUT A JURY. EACH OF THE PARTIES HERETO FURTHER WAIVES ANY RIGHT TO SEEK TO CONSOLIDATE ANY SUCH LEGAL PROCEEDING IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT OR HAS NOT BEEN WAIVED.
10.Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions shall nevertheless continue in full force and effect.
11.Further Assurances. The parties will execute such further instruments and take such further actions as may be reasonably necessary to carry out the intent of this Agreement.
12.Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally, telecopied (with a confirmation thereof), two (2) Business Days after being mailed by registered or certified mail (return receipt requested), or the Business Day
4
after being sent if sent for next day delivery to a domestic address by recognized overnight delivery service (e.g., Federal Express) to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):
(a) if to the Purchaser:
The Spectranetics Corporation
9965 Federal Drive
9965 Federal Drive
Colorado Springs, CO 80921
Telephone: (719) 447-2000
Telecopier: (719) 447-2022
Attention: Chief Executive Officer
Telephone: (719) 447-2000
Telecopier: (719) 447-2022
Attention: Chief Executive Officer
with a copy to:
The Spectranetics Corporation
9965 Federal Drive
Colorado Springs, CO 80921
Telephone: (719) 447-2000
Telecopier: (719) 447-2022
Attention: General Counsel
Telephone: (719) 447-2000
Telecopier: (719) 447-2022
Attention: General Counsel
(b) if to the Seller Parties:
Kensey Nash Corporation
735 Pennsylvania Drive
735 Pennsylvania Drive
Exton, PA 19341
Telephone: (484) 713-2100
Telecopier: (484) 713-2900
Attention: Joseph W. Kaufmann
Telephone: (484) 713-2100
Telecopier: (484) 713-2900
Attention: Joseph W. Kaufmann
with a copy to:
Kensey Nash Corporation
735 Pennsylvania Drive
735 Pennsylvania Drive
Exton, PA 19341
Telephone: (484) 713-2100
Telecopier: (484) 713-2909
Attention: Vice President of Legal Affairs
Telephone: (484) 713-2100
Telecopier: (484) 713-2909
Attention: Vice President of Legal Affairs
13.No Waiver. The failure of any party to enforce any provision of this Agreement shall not be construed as a waiver of that provision, nor prevent that party thereafter from enforcing that provision or any other provision of this Agreement.
14.Arms Length Agreement. This Agreement has been negotiated and prepared at the mutual request, direction and construction of the Seller Parties and the Purchaser, at arms length,
5
with the advice and participation of counsel, and will be interpreted in accordance with its terms without favor to any party.
15.Counterparts; Electronic Delivery. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, and all of which, when taken together, shall constitute one and the same instrument. Signatures sent by facsimile transmission, by email of a .pdf, .tiff or similar file or other electronic transmission shall be deemed to be original signatures.
16.Attorneys’ Fees. In the event of any proceeding arising out of or related to this Agreement, the prevailing party shall be entitled to recover from the losing party all of its costs and expenses incurred in connection with such proceeding, including court costs and reasonable attorneys’ fees, whether or not such proceeding is prosecuted to judgment.
17.Headings. Section headings used in this Agreement are for convenience only and form no part or in any way modify or define the text of meaning or any provision of this Agreement.
[Signature page follows]
6
IN WITNESS WHEREOF, the Seller Parties and the Purchaser have duly executed this Non-Competition Agreement as of the day and year first written above.
KENSEY NASH CORPORATION
By: /s/ Joseph Kaufmann
Name: Joseph Kaufmann
Title: CEO
ILT ACQUISITION SUB, INC.
By: /s/ Joseph Kaufmann
Name: Joseph Kaufmann
Title: President
THE SPECTRANETICS CORPORATION
By: /s/ Wade Bowe
Name: Wade Bowe
Title: Vice President
7